Clinical trial

Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis

Recruiting now · Not applicable · 1 countries · Registry ID NCT03868592

Recruiting nowNot applicableInterventional

What this study is about

It is not known how much improvement in insulin regulated lipolysis (the breakdown of triglycerides) occurs following substantial, sustained weight loss. Researchers will test the effects of inflammation and lipolysis regulation in people before and after bariatric surgery (sleeve gastrectomy) to answer these questions.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 65 Years
SexAll
Healthy volunteersNot accepted
ConditionObesity, Morbid

Full registry criteria

Inclusion Criteria: * BMI 40 - 50 kg/m2. * Mo active physical illness that would interfere with mobility or weight loss after bariatric surgery Exclusion Criteria: * Type 1 or Type 2 Diabetes diagnosis or fasting plasma glucose ≥126 mg/dL * Active coronary artery disease * Participation in structured exercise (\>2 times per week for 30 minutes or longer) * Smoking * Medications known to affect adipose tissue metabolism (e.g., beta blockers, corticosteroids) * Renal insufficiency (serum creatinine \> 1.5mg/dl) * Chronic active liver disease (Bilirubin \> 17mmol/L, AST \> 144 IU/L, or ALT\>165IU/L) * Pregnancy or breastfeeding.

Treatments and study arms

Gastric sleeve/bariatric surgery

Procedure

weight loss

Primary outcomes

adipose macrophage content, adipose IL-6 and TNF gene expressionBefore bariatric surgery and approximately 1 year after surgery

Adipose tissue macrophage content as assessed by immunohistochemistry using stains for CD36, CD14 and CD206 will be done. mRNA expression for IL-6 and TNF will be measured

insulin regulation of lipolysis (IC50)Before bariatric surgery and approximately 1 year after surgery

The ability of insulin to suppress FFA palmitate release will be assessed using a 2-step insulin clamp and isotope dilution techniques for palmitate kinetics

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Mayo Clinic🇺🇸 Rochester, Minnesota, United States
Reich PamelaContact
Michael D Jensen, MDPrincipal Investigator